The Tuberculosis Pandemic – A Call to Action: Presentations and Recordings

Tuesday, 21 March 2023

Session 1 | Update on the TB Epidemic, Poverty and Politics

Welcome Jürg Utzinger, Director, Swiss TPH

Introductory Remarks, Lucica Ditiu, Executive Director, Stop TB Partnership, Switzerland

TB in the World Today: Update on the Epidemic and Progress in the Response, Matteo Zignol, Director a.i., Global TB Programme, WHO, Switzerland

The Burden of TB: DALYs, Socioeconomic Consequences, Stigma, Christian Auer, Swiss TPH

Community Perspective, Rhea Lobo, TB survivor and Board Member (Community Delegation) of Stop TB Partnership, Switzerland

Why Social Protection is Essential to End TB, Delia Boccia, WHO Consultant, Switzerland

TB Advocacy, Stijn Deborggraeve, Médecins Sans Frontières, The Netherlands; Austin Arinze Obiefuna, Afro Global Alliance and Stop TB Partnership Board, Ghana

Global Plan to End TB – How Can We End TB and How Much it Will Cost, Lucica Ditiu, Stop TB Partnership, Switzerland; Peter Sands, Executive Director, the Global Fund, Switzerland

The TB Caucus: Its Mission, Nick Herbert, Co-Chair of TB Caucus, and member of UK Parliament; Alesia Matusevych, TB Caucus, Portugal

The TB Caucus – a European Perspective, Tina Rudolph, member of German Parliament

Reaction from a Swiss Politician, the UNION and WHO, Eva Herzog, Member of Swiss Parliament, Switzerland; Kobto Ghislain Koura, Director TB Department, International Union Against Tuberculosis and Lung Disease, France; Tereza Kasaeva, Assistant Director-General, Universal Health Coverage, WHO

Session 2 | Understanding the Biology

Revisiting the Natural History of Tuberculosis. Why does it Matter? Alberto García-Basteiro, Instituto de Salud Global de Barcelona, Spain

Ecology and Evolution of MDR-TB, Sébastien Gagneux, Swiss TPH

Advances in Mycobacterium Tuberculosis Genomics to Inform TB Control, Iñaki Comas, Tuberculosis Genomics Unit, Instituto de Biomedicina de Valencia, Spain

Dissecting Immune Responses along the Spectrum of Tuberculosis ex vivo in a Human 3D Granuloma Model, Damien Portevin, Swiss TPH

Immunity to Tuberculosis: Re-evaluating What We Think We Know, Carolyn King, Department of Biomedicine, University of Basel, Switzerland

TB Basic Biology: the Pathogen, Margarida Saraiva, Life and Health Sciences Research Institute, University of Minho, Braga, Portugal

TB and Diabetes, Dorothy Yebuoah-Manu, Noguchi Memorial Institute for Medical Research, University of Ghana

Wednesday, 22 March 2023

Session 3 | From Science to Impact

TB Diagnostics: Newer Tools and Outlook, Adam Penn-Nicholson, FIND, Switzerland

Active Case Finding, Community Screening, Klaus Reither, Swiss TPH

Prevention is better than Cure: Development of More Effective TB Vaccines, Tom Scriba, University of Cape Town, South Africa

The Emerging Phenotype of Ancestral Tuberculosis, Bouke de Jong, Institute of Tropical Medicine, Belgium

The Current TB Drug Trial Landscape and the Need for Capacity Development, Nestani Tukvadze, National Center for Tuberculosis and Lung Diseases, Georgia

Paediatric TB: Doing More with Less, Nicole Ritz, Children’s Hospital Lucerne and University Children’s Hospital Basel, Switzerland

Session 4 | TB in Special Populations and Health Systems

TB Treatment and Drug Development – the Value of Cohort Studies, Jerry Hella, Ifakara Health Institute, Tanzania

Responding to Rapidly Changing HIV and Tuberculosis Epidemiology in Africa, Peter McPherson, School of Health and Wellbeing, University  of Glasgow, UK

Host Specificity in Human and Animal Tuberculosis through the Lens of Genomics, Daniela Brites, Swiss TPH

TB in Prisons, Jason Andrews, Stanford Medicine, USA

Addressing the intersection between Gender and Social Determinants to End TB, Bertie Squire, Liverpool School of Tropical Medicine, UK; Chukwuebuka Ugwu, Zankli Research Centre, Bingham University, Nigeria

Strengthened Health Care Systems for Ending TB, Annabel Baddeley, WHO, Switzerland